|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | Jul 17 '25 | Sale | 163.55 | 19,137 | 3,129,830 | 10,658 | Jul 18 04:12 PM |
| JNJ | REED JOHN C | Officer | Jul 17 '25 | Proposed Sale | 163.55 | 19,137 | 3,129,831 | Jul 17 04:05 PM | |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | May 01 '25 | Option Exercise | 0.00 | 25,255 | 0 | 40,797 | May 05 05:10 PM |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | Feb 15 '25 | Option Exercise | 0.00 | 1,350 | 0 | 15,927 | Feb 18 09:11 PM |
| JNJ | REED JOHN C | EVP, Innovative Medicine, R&D | May 01 '24 | Option Exercise | 0.00 | 22,255 | 0 | 22,561 | May 03 04:31 PM |
| RPRX | REED JOHN C | Director | Oct 02 '08 | Buy | 6.50 | 25,000 | 162,500 | 25,000 | Oct 06 06:46 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite